Edition:
United States

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.85USD
3:59pm EST
Change (% chg)

$0.41 (+9.23%)
Prev Close
$4.44
Open
$4.40
Day's High
$5.11
Day's Low
$4.40
Volume
6,551
Avg. Vol
8,257
52-wk High
$8.56
52-wk Low
$3.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.296
Jun '17 0.00 -0.288
Mar '17 0.00 -0.079
FY 2016 Dec '16 0.00 -0.098
Sep '16 0.00 -0.065
Jun '16 0.00 -0.092
Mar '16 0.00 -0.126
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.23 35.64
P/E High - Last 5 Yrs. -- 41.43 46.80
P/E Low - Last 5 Yrs. -- 23.37 24.18
Beta -- 0.81 0.81
Price to Sales (TTM) -- 6.23 8.67
Price to Book (MRQ) 1.88 4.34 5.21
Price to Tangible Book (MRQ) 1.88 4.82 6.35
Price to Cash Flow (TTM) -- 23.04 26.03
% Owned Institutions 1.40 1.25 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.59 1.51
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.24 5.24
Payout Ratio(TTM) -- 45.32 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.65 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 6.38 7.55
Sales - 5 Yr. Growth Rate -- 9.89 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -353.25 14.70 16.86
EPS (TTM) vs TTM 1 Yr. Ago -74.24 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.51
Capital Spending - 5 Yr. Growth Rate -- 14.63 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.42
Current Ratio (MRQ) 13.15 3.34 3.38
LT Debt to Equity (MRQ) 0.00 9.17 12.01
Total Debt to Equity (MRQ) 0.00 12.36 15.38
Interest Coverage (TTM) -3.81 45.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.23 54.84
Gross Margin - 5 Yr. Avg. -- 52.57 52.61
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.47 9.77
Operating Margin (TTM) -- 11.50 2.53
Operating Margin - 5 Yr. Avg. -- 14.27 5.00
Pre-Tax Margin (TTM) -- 11.87 3.34
Pre-Tax Margin - 5 Yr. Avg. -- 14.55 5.26
Net Profit Margin (TTM) -- 8.24 -0.18
Net Profit Margin - 5 Yr. Avg. -- 10.88 1.54
Effective Tax Rate (TTM) -- 22.44 22.12
Effective Tax Rate - 5 Yr. Avg. -- 23.60 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 922,196,718 822,216,427
Net Income/Employee (TTM) -- 107,909,384 96,151,835
Receivable Turnover (TTM) -- 5.30 5.40
Inventory Turnover (TTM) -- 2.60 3.51
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.06 11.13 10.70
Return on Assets - 5 Yr. Avg. -- 12.64 12.00
Return on Investment (TTM) -70.09 14.02 13.57
Return on Investment - 5 Yr. Avg. -- 16.55 15.72
Return on Equity (TTM) -81.83 15.49 15.19
Return on Equity - 5 Yr. Avg. -- 17.63 16.94
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 39.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.40%
# of Holders: 8
Total Shares Held: 143,564
3 Mo. Net Change: 3,201
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 5
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.